Clinical studies recruiting near Mechelen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0205) · Merck Sharp & Dohme LLC · NCT06136559 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · AZ Sint-Maarten · Pfizer · NCT06758401 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · AZ Sint-Maarten · Pfizer · NCT07144280 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Meclinas · Eli Lilly and Company · NCT07353931 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0306) · Merck Sharp & Dohme LLC · NCT06890884 Ebastine Versus Mebeverine in IBS Patients
Phase 3 · AZ St-Maarten · Guy Boeckxstaens · NCT05815602 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · AZ Sint-Maarten · Eli Lilly and Company · NCT06119581 Follow-up and Outcome of Operative Treatment With Decompressive Release Of The Peroneal Nerve
NA · AZ Sint-Maarten · Universitaire Ziekenhuizen KU Leuven · NCT04695834 Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
Phase 4 · AZ Sint Maarten · Universitaire Ziekenhuizen KU Leuven · NCT05169593 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · AZ Sint-Maarten ( Site 2904) · Merck Sharp & Dohme LLC · NCT03486873 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · AZ Sint-Maarten · Eli Lilly and Company · NCT07392190 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · AZ Sint-Maarten · Hoffmann-La Roche · NCT05878769 Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
NA · AZ Sint-Maarten · Cancer Research Antwerp · NCT06613295 Differential Target Multiplexed Spinal Cord Stimulation
Phase N/A · AZ Sint-Maarten · Moens Maarten · NCT05068011 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · Algemeen Ziekenhuis Sint Maarten-Emmaus vzw · Amgen · NCT06252649 Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-
NA · AZ Sint-Maarten · Jules Bordet Institute · NCT06925984 A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Phase 3 · Research Site · AstraZeneca · NCT06549595 A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple My
Phase 2 · AZ Sint Maarten Algemeen Ziekenhuis Emmaus · Regeneron Pharmaceuticals · NCT06140524 Neuro-Complex & Multi Supplements for Migraine Prevention
NA · Meclinas · Benfida, a department of Handi-Move · NCT07015411 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Pr
Phase 3 · AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 1102) · Merck Sharp & Dohme LLC · NCT06717347 Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
NA · AZ Sint Maarten · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06719440 Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC
NA · AZ Sint-Maarten · Universitaire Ziekenhuizen KU Leuven · NCT04688528 R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery
NA · AZ Sint Maarten Mechelen · Universitaire Ziekenhuizen KU Leuven · NCT07313566 A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Phase 2 · AZ Sint-Maarten · Pfizer · NCT06977581 A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Phase 3 · Meclinas · Eli Lilly and Company · NCT07219966 Belgian Registry on Coronary Function Testing
Phase N/A · AZ Sint-Maarten · University Hospital, Antwerp · NCT06089031 Effect of Plant Based High Energy High Protein Oral Nutritional Supplement on Nutritional Intake in Patients With or at
NA · Meclinas · Nutricia Research · NCT06781619

Look up another city

Look up another condition